| Miss Shelby Lynn Jestice, OTR/L | |
|
176 W University Pkwy Ste E, Jackson, TN 38305-1618 | |
| (731) 300-4950 | |
| Not Available |
| Full Name | Miss Shelby Lynn Jestice |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 176 W University Pkwy Ste E, Jackson, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194449355 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 6894 (Tennessee) | Primary |
| Provider Name | Patterson Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770928533 PECOS PAC ID: 8022259878 Enrollment ID: O20130722000132 |
News Archive
Bladder cancer is a painful and sometimes life-threatening condition that patients can find difficult to talk about, with many becoming homebound as they cope with debilitating side effects such as incontinence.
The Results for Development Institute's Center for Global Health R&D Policy Assessment blog features an interview with Judit Rius Sanjuan, U.S. manager of the Access Campaign of Medecins Sans Frontieres (MSF), who discusses the final report of the WHO Consultative Expert Working Group on Research and Development: Financing and Coordination.
Researchers at Karolinska Institutet in Sweden and their Danish colleagues have monitored HPV-vaccinated girls via patient data registries in order to examine the incidence of a wide range of diseases and thus determine if there are any serious adverse effects of the vaccine. Their results show no significant increase of the examined diseases in the vaccinated girls relative to their unvaccinated peers.
A brief report published in Acta Paediatrica points to the dangers of replacing breast milk or infant formula with a non-dairy drink before one year of age.
Viron Therapeutics Inc. today announced that the results of Viron's Phase 2a trial for VT-111 were published today in Circulation: Cardiovascular Interventions. In the study led by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, VT-111, also known as Serp-1, met both its primary and secondary endpoints of safety and biological activity in Acute Coronary Syndrome patients receiving coronary stents.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Shelby Lynn Jestice, OTR/L 5760 Highway 179, Whiteville, TN 38075-5316 Ph: (731) 609-0965 | Miss Shelby Lynn Jestice, OTR/L 176 W University Pkwy Ste E, Jackson, TN 38305-1618 Ph: (731) 300-4950 |
News Archive
Bladder cancer is a painful and sometimes life-threatening condition that patients can find difficult to talk about, with many becoming homebound as they cope with debilitating side effects such as incontinence.
The Results for Development Institute's Center for Global Health R&D Policy Assessment blog features an interview with Judit Rius Sanjuan, U.S. manager of the Access Campaign of Medecins Sans Frontieres (MSF), who discusses the final report of the WHO Consultative Expert Working Group on Research and Development: Financing and Coordination.
Researchers at Karolinska Institutet in Sweden and their Danish colleagues have monitored HPV-vaccinated girls via patient data registries in order to examine the incidence of a wide range of diseases and thus determine if there are any serious adverse effects of the vaccine. Their results show no significant increase of the examined diseases in the vaccinated girls relative to their unvaccinated peers.
A brief report published in Acta Paediatrica points to the dangers of replacing breast milk or infant formula with a non-dairy drink before one year of age.
Viron Therapeutics Inc. today announced that the results of Viron's Phase 2a trial for VT-111 were published today in Circulation: Cardiovascular Interventions. In the study led by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, VT-111, also known as Serp-1, met both its primary and secondary endpoints of safety and biological activity in Acute Coronary Syndrome patients receiving coronary stents.
› Verified 9 days ago
Mrs. Brynn Shellene Smith, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 45 Forest Cv, Jackson, TN 38301 Phone: 731-424-4200 | |
Ms. Johnetta Newson, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 620 Skyline Dr, Jackson, TN 38301 Phone: 731-541-5000 | |
Allison Ganier Havercamp, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 34 Garland Dr, Jackson, TN 38305 Phone: 731-668-3322 | |
Mrs. Mary Elizabeth Craigie, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 23 Glenwood Dr, Jackson, TN 38305 Phone: 731-664-9095 | |
Penny Ann Gibson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 34 Garland Dr, Jackson, TN 38305 Phone: 731-668-9070 | |
Hayley Alexandria Lumpkin, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 34 Garland Dr, Jackson, TN 38305 Phone: 731-668-9070 Fax: 731-660-8739 | |
Amanda Diez Stewart, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 32 Garland Dr, Jackson, TN 38305 Phone: 731-664-3645 Fax: 731-668-6549 |